The latest research study “Cancer Cachexia Market Growth: Global Industry Trends, Share, Size, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global cancer cachexia market reached a value of US$ 1.88 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 2.53 Billion by 2027, exhibiting a CAGR of 4.80% during 2022-2027.
A multifactorial wasting illness known as cancer cachexia includes weight loss, anaemia, systemic inflammation, anorexia, asthenia, involuntary loss of lean body mass and appetite, and a poor protein and energy balance. It is brought on by a number of chronic illnesses, including chronic renal failure, multiple sclerosis, HIV, and chronic obstructive pulmonary disease (COPD). Progestogen, corticosteroids, and combination therapies are some of the treatments that can be used to treat cancer cachexia in order to reduce the symptoms, improve the response to chemotherapy, enhance patient quality of life, and raise the survival rate.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Download a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/cancer-cachexia-market/requestsample
Cancer Cachexia Market Trends and Drivers:
The global cancer cachexia market is primarily driven by the rising incidences of cancer cachexia among cancer patients. In addition, patients and healthcare providers are shifting toward combinational therapies for improving lean body mass (LBM) through pharmacological and non-pharmacological treatment.
Along with this, the growing adoption of several appetite stimulants, such as megestrol acetate, dexamethasone, and methylprednisolone, for enhancing digestion has catalyzed the product demand. Furthermore, the increasing public and private investments in research and development (R&D) activities to introduce advanced therapeutics and drugs for cancer cachexia treatment have positively influenced the market growth.
Other factors, including the growing awareness regarding the availability of novel therapeutic drugs for cancer cachexia, expanding geriatric population, favorable government initiatives, improving healthcare infrastructure, and technological advancements, are also anticipated to propel the market growth.
Global Cancer Cachexia Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
List Of Major Key Players :
AAVogen Inc., Actimed Therapeutics Ltd., Aphios Corporation, Artelo Biosciences Inc., AVEO Pharmaceuticals Inc., Fresenius Kabi AG (Fresenius SE & Co. KGaA), Helsinn Healthcare SA, Merck & Co. Inc., NGM Biopharmaceuticals Inc., Pfizer Inc. and Tetra Bio-Pharma.
The report has segmented the market on the basis of region, therapeutics, mode of action and distribution channel.
Breakup by Therapeutics:
- Combination Therapy
Breakup by Mode of Action:
- Appetite Stimulators
- Weight Loss Stabilizers
Market Breakup by Distribution Channel:
- Hospital Stores
- Retail Pharmacy
- Online Pharmacy
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/cancer-cachexia-market
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800